HANCE SCARBOROUGH lobbying for ALLIANCE FOR PHARMACY COMPOUNDING

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $50,000.00 income · posted Apr 17, 2025

Bills named in this filing 1

HR 167
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023

Lobbying activity 3

Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2025 Appropriations. HR167, the Patient Access to Urgent Use Compounded Medication Act